Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Analysis, Price Trend, Industry Overview

Market Insights

As per recent research by MarkNtel Advisors, “The Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trialss market is likely to grow at a CAGR of 23.6% during 2021-26.

“In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecasts for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn't take long for the team to deliver the most recent version of the report.”

Request Free Sample Report: https://www.marknteladvisors.com/query/request-sample/artificial-intelligence-enabled-drug-discovery-clinical-trials.html

Market Driver: Mounting Technological Advancement to Propel the Market Growth

Burgeoning technological advancements like AI, 4K Imaging, and IoT (Internet of Things) have resulted in surging the demand for integrating these high-end technologies in the healthcare industry. AI helps provide patient-centric treatment, better diagnostic services, and accurate decision-making, thereby recognizing errors in the current situations and providing better alternatives in complex scenarios. Hence, AI technology is likely to encourage the growth of the Drug Discovery and Clinical Trials Market.

Market Segmentation and Consumer Behavior:

By Component

Software
Service

By Application

Data Aggregation and Analysis
Clinical Trials
Drug Design
Drug Characterization
Biomarker Research

By Therapeutic Application

Oncology
Cardiovascular Disease
Nervous System Disease
Respiratory Disorder
Metabolic Disorder
Immunologic Disease
Infectious Disease
Others

By End-User

Biopharmaceutical Industry
Contract Research Organization (CROs)
Academic Institutes and Research Centers

Read Full Report: https://www.marknteladvisors.com/research-library/artificial-intelligence-enabled-drug-discovery-clinical-trials.html

Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Geographical Analysis:

By Region:

North America
South America
Europe
Asia-Pacific
Middle East Africa

Key Players and Competitive Strategies in the Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market

Several prominent players dominate the Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market, including:

Accutar Biotechnology
Ardigen
Atomwise Inc.
AiCure, LLC
Berg LLc
Cloud Pharmaceuticals
Biovista
Cyclica Inc.
Symphony Innovations
GNS Healthcare

Report Delivery - MarkNtel Advisors offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Questions Addressed in this Study

1.What factors are driving the Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market growth?

2.How is the Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market expected to grow over the next five years?

3.What are the key insights into the current trends in the Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market?

4.What is the current size of the Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market, and how is it projected to change in the future?

6.What is the future outlook for the Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market in terms of technological advancements and market expansion?

Request Customization - https://www.marknteladvisors.com/query/request-customization/artificial-intelligence-enabled-drug-discovery-clinical-trials.html

Read Blog:

Why MarkNtel Advisors?

MarkNtel Advisors is a leading research, consulting, data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial varied client base, including multinational corporations, financial institutions, governments, individuals, among others.

Our specialization in niche industries emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing forecasting, trend analysis, among others, for 15 diverse industrial verticals.